Two copper(II) complexes [CuL(1)Cl]ClO(4) and [CuL(2)MeCN](ClO(4))(2)xH(2)O were synthesized (L(1)= 1-(benzimidazole-2-ylmethyl)-1,4,7-triazacyclononane, L(2)= 1,4-bis(benzimidazole-2-ylmethyl)-1,4,7-triazacyclonone). The benzimidazole groups were N-substituents of tacn, and the complexes are more stable than their parents. They are able to catalyse the dismutation of superoxide anion in aqueous solutions at physiological pH and in bovine serum albumin solution (0.5 mg ml(-1)). X-ray structure analysis and EPR and electronic spectra show that the structure of complex is more similar to the Cu(II) centre of Cu(2)Zn(2)SOD than that. Comparing with other Cu(II) complexes, the complex possesses both high SOD activity and highly thermodynamic stability.
No takes yet. Share an insight, caveat, or question.
Li et al. (2004) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: